This introductory workshop provides an overview of startup companies in life sciences and healthcare, touching on the foundational concepts that are most important for early stage founders to get a handle on. You’ll learn: idea generation and evaluation, team formation, prototypes and PoCs, intellectual property considerations, technology commercialization, regulatory strategy, fund raising, corporate structure, the significance of customers and stakeholders, and identifying unmet clinical needs. And since so many life- science startups are borne out of research labs, we’ll take a look at the translation of technology from the bench to bedside — from a researcher’s point of view.
Speaker Name: Michael Fenn
Michael is currently Head of External Innovation at Dewpoint Therapeutics, and is also a venture partner at Iaso Ventures.
Previously, Michael was Director of Healthcare & Life Sciences at Harvard Innovation Labs, overseeing startup incubation programs and advising Harvard-affiliated founders. Michael also co-led initial planning of Life Lab Longwood, a new translational biotech incubator at Harvard Medical School.
Michael was formerly an Assistant Professor of Biomedical Engineering at Florida Institute of Technology where his lab focused on the bio-nano interface with applications in drug delivery, biosensing, and regenerative medicine. He successfully oversaw the spinout of two companies from his lab, including a YC-backed, ML-driven diagnostic startup that was later acquired.
Michael received his Ph.D. in Biomedical Engineering, M.S. in Materials Science & Engineering, and B.S. in Chemistry/Biochemistry, all from the University of Florida.